These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 1928974)
21. The preclinical and clinical pharmacology of SK&F 104353, a potent and selective peptidoleukotriene receptor antagonist. Torphy TJ; Faiferman I; Gleason JG; Hall RF; Lewis MA; Broom C; Helfrich HM; Newton JF; Hay DW Ann N Y Acad Sci; 1991; 629():157-67. PubMed ID: 1659277 [No Abstract] [Full Text] [Related]
22. Inhibition of exercise-induced bronchoconstriction by MK-571, a potent leukotriene D4-receptor antagonist. Manning PJ; Watson RM; Margolskee DJ; Williams VC; Schwartz JI; O'Byrne PM N Engl J Med; 1990 Dec; 323(25):1736-9. PubMed ID: 2174121 [TBL] [Abstract][Full Text] [Related]
23. Concentration-dependent, stereoselective inhibition of the endotoxin-induced hemoconcentration in conscious rats with the peptidoleukotriene receptor antagonist SK & F 104353. Smith EF; Kinter LB; Jugus M; Eckardt RD; Newton JF Eicosanoids; 1989; 2(2):101-7. PubMed ID: 2560662 [TBL] [Abstract][Full Text] [Related]
24. Protective and bronchodilator effects of prostaglandin E and salbutamol in aspirin-induced asthma. Szczeklik A; Mastalerz L; Nizankowska E; Cmiel A Am J Respir Crit Care Med; 1996 Feb; 153(2):567-71. PubMed ID: 8564099 [TBL] [Abstract][Full Text] [Related]
25. Salmeterol prevents aspirin-induced attacks of asthma and interferes with eicosanoid metabolism. Szczeklik A; Dworski R; Mastalerz L; Prokop A; Sheller JR; Nizankowska E; Cmiel A; Oates JA Am J Respir Crit Care Med; 1998 Oct; 158(4):1168-72. PubMed ID: 9769277 [TBL] [Abstract][Full Text] [Related]
26. Pharmacologic profile of SK&F 104353: a novel, potent and selective peptidoleukotriene receptor antagonist in guinea pig and human airways. Hay DW; Muccitelli RM; Tucker SS; Vickery-Clark LM; Wilson KA; Gleason JG; Hall RF; Wasserman MA; Torphy TJ J Pharmacol Exp Ther; 1987 Nov; 243(2):474-81. PubMed ID: 2824747 [TBL] [Abstract][Full Text] [Related]
27. Effect of the 5-lipoxygenase inhibitor ZD2138 on aspirin-induced asthma. Nasser SM; Bell GS; Foster S; Spruce KE; MacMillan R; Williams AJ; Lee TH; Arm JP Thorax; 1994 Aug; 49(8):749-56. PubMed ID: 8091318 [TBL] [Abstract][Full Text] [Related]
28. A specific LTD4/LTE4-receptor antagonist improves pulmonary function in patients with mild, chronic asthma. Cloud ML; Enas GC; Kemp J; Platts-Mills T; Altman LC; Townley R; Tinkelman D; King T; Middleton E; Sheffer AL Am Rev Respir Dis; 1989 Nov; 140(5):1336-9. PubMed ID: 2554766 [TBL] [Abstract][Full Text] [Related]
29. Montelukast is only partially effective in inhibiting aspirin responses in aspirin-sensitive asthmatics. Stevenson DD; Simon RA; Mathison DA; Christiansen SC Ann Allergy Asthma Immunol; 2000 Dec; 85(6 Pt 1):477-82. PubMed ID: 11152169 [TBL] [Abstract][Full Text] [Related]
30. [Sodium cromoglycate nebulized solution has an acute bronchodilative effect in patients with aspirin-intolerant asthma (AIA)]. Imokawa S; Sato A; Taniguchi M; Toyoshima M; Nakazawa K; Hayakawa H; Chida K Arerugi; 1992 Oct; 41(10):1515-20. PubMed ID: 1482300 [TBL] [Abstract][Full Text] [Related]
31. A six week double blind, placebo controlled, crossover study of the effect of misoprostol in the treatment of aspirin sensitive asthma. Wasiak W; Szmidt M Thorax; 1999 Oct; 54(10):900-4. PubMed ID: 10491452 [TBL] [Abstract][Full Text] [Related]
32. Antagonism of leukotriene C4, leukotriene D4 and leukotriene E4 vasoconstrictor responses in the conscious rat with the peptidoleukotriene receptor antagonist SK&F 104353: evidence for leukotriene D4 receptor heterogeneity. Smith EF; Slivjak MJ; Eckardt RD; Newton JF J Pharmacol Exp Ther; 1989 Jun; 249(3):805-11. PubMed ID: 2543811 [TBL] [Abstract][Full Text] [Related]
33. Urinary leukotriene E4 in bronchial asthma. Smith CM; Hawksworth RJ; Thien FC; Christie PE; Lee TH Eur Respir J; 1992 Jun; 5(6):693-9. PubMed ID: 1321055 [TBL] [Abstract][Full Text] [Related]
34. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial). Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening A; Haahtela T; Holgate ST; Picado C; Leff JA Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768 [TBL] [Abstract][Full Text] [Related]
35. Effect of an oral leukotriene D4 antagonist L-649,923 on the response to inhaled antigen in asthma. Britton J; Hanley S; Tattersfield A Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():1003-6. PubMed ID: 2960142 [No Abstract] [Full Text] [Related]
36. Dose-related antagonism of leukotriene D4-induced bronchoconstriction by p.o. administration of LY-171883 in nonasthmatic subjects. Phillips GD; Rafferty P; Robinson C; Holgate ST J Pharmacol Exp Ther; 1988 Aug; 246(2):732-8. PubMed ID: 3404455 [TBL] [Abstract][Full Text] [Related]
37. L-648,051, a novel cysteinyl-leukotriene antagonist is active by the inhaled route in man. Evans JM; Barnes NC; Zakrzewski JT; Sciberras DG; Stahl EG; Piper PJ; Costello JF Br J Clin Pharmacol; 1989 Aug; 28(2):125-35. PubMed ID: 2775617 [TBL] [Abstract][Full Text] [Related]
38. Increased excretion of leukotriene E4 during aspirin-induced asthma. Knapp HR; Sladek K; Fitzgerald GA J Lab Clin Med; 1992 Jan; 119(1):48-51. PubMed ID: 1309376 [TBL] [Abstract][Full Text] [Related]
39. The effect of aspirin desensitization on urinary leukotriene E4 concentrations in aspirin-sensitive asthma. Nasser SM; Patel M; Bell GS; Lee TH Am J Respir Crit Care Med; 1995 May; 151(5):1326-30. PubMed ID: 7735581 [TBL] [Abstract][Full Text] [Related]